Detection of minimal residual disease in B lymphoblastic leukemia using viSNE
Author:
Affiliation:
1. Department of Pathology & Laboratory Medicine; Hartford Hospital; Hartford Connecticut
2. Department of Biological Sciences; Columbia University; New York New York
3. Department of Systems Biology; Columbia University; New York New York
Publisher
Wiley
Subject
Cell Biology,Histology,Pathology and Forensic Medicine
Reference34 articles.
1. Minimal residual disease in acute lymphoblastic leukemia;Campana;ASH Educ Program Book,2010
2. Detection of minimal residual disease in pediatric acute lymphoblastic leukemia;Gaipa;Cytometry Part B Clin Cytom,2013
3. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: A children's oncology group study;Borowitz;Blood,2008
4. Risk of relapse of childhood acute lymphoblastic leukemia is predicted by flow cytometric measurement of residual disease on day 15 bone marrow;Basso;J Clin Oncol,2009
5. Immunologic minimal residual disease detection in acute lymphoblastic leukemia: A comparative approach to molecular testing;Coustan-Smith;Best Pract Res Clin Haematol,2010
Cited by 40 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The Evolving Landscape of Flowcytometric Minimal Residual Disease Monitoring in B-Cell Precursor Acute Lymphoblastic Leukemia;International Journal of Molecular Sciences;2024-04-30
2. Minimal residual disease assessment in B‐cell precursor acute lymphoblastic leukemia by semi‐automated identification of normal hematopoietic cells: A EuroFlow study;Cytometry Part B: Clinical Cytometry;2023-09-22
3. Computational flow cytometry provides accurate assessment of measurable residual disease in chronic lymphocytic leukaemia;British Journal of Haematology;2023-04-13
4. Highly sensitive single tube B‐lymphoblastic leukemia/lymphoma minimal/measurable residual disease test robust to surface antigen directed therapy;Cytometry Part B: Clinical Cytometry;2023-03-30
5. Laboratory Aspects of Minimal / Measurable Residual Disease Testing in B-Lymphoblastic Leukemia;Clinics in Laboratory Medicine;2023-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3